Complete financial analysis of Omega Healthcare Investors, Inc. (OHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omega Healthcare Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Georg Fischer AG (GF.SW) Income Statement Analysis – Financial Results
- Big 5 Sporting Goods Corporation (BGFV) Income Statement Analysis – Financial Results
- Ratnaveer Precision Engineering Limited (RATNAVEER.NS) Income Statement Analysis – Financial Results
- Namsun Aluminum Co., Ltd. (008350.KS) Income Statement Analysis – Financial Results
- ORG Technology Co.,Ltd. (002701.SZ) Income Statement Analysis – Financial Results
Omega Healthcare Investors, Inc. (OHI)
About Omega Healthcare Investors, Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 949.74M | 878.24M | 1.06B | 892.38M | 928.83M | 881.68M | 908.39M | 900.83M | 743.62M | 504.79M | 418.71M | 350.46M | 292.20M | 258.32M | 197.44M | 193.76M | 159.56M | 135.69M | 105.81M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Cost of Revenue | 106.97M | 16.97M | 13.72M | 13.76M | 16.14M | 29.84M | 99.07M | 58.73M | 17.68M | 3.66M | 415.00K | 272.00K | 653.00K | 8.00M | 159.00K | 5.58M | 1.42M | 0.00 | 5.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 842.77M | 861.28M | 1.05B | 878.62M | 912.69M | 851.84M | 809.32M | 842.10M | 725.94M | 501.13M | 418.30M | 350.19M | 291.55M | 250.32M | 197.28M | 188.18M | 158.14M | 135.69M | 100.36M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Gross Profit Ratio | 88.74% | 98.07% | 98.71% | 98.46% | 98.26% | 96.62% | 89.09% | 93.48% | 97.62% | 99.27% | 99.90% | 99.92% | 99.78% | 96.90% | 99.92% | 97.12% | 99.11% | 100.00% | 94.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.49 | 0.39 | 0.18 | 0.37 | 0.34 | 0.12 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 15.05M | 11.74M | 11.70M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00M | 20.63M | -2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 23.05M | 32.37M | 9.60M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Other Expenses | 0.00 | 401.07M | 419.75M | 367.92M | 301.68M | 287.97M | 10.41M | 286.49M | 276.10M | 129.93M | 131.03M | 113.89M | 106.78M | 84.62M | 47.46M | 71.74M | -398.00K | 32.91M | 25.31M | 24.14M | 0.00 | 0.00 | 229.33M | 296.50M | 24.21M | 21.54M | 16.91M | 13.69M | -16.60M | -9.40M | -4.60M | -1.20M |
| Operating Expenses | 81.50M | 469.00M | 482.92M | 426.36M | 358.34M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.21M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Cost & Expenses | 188.47M | 485.97M | 496.64M | 440.13M | 374.49M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.86M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Interest Income | 0.00 | 123.92M | 234.60M | 223.39M | 856.00K | 313.00K | 267.00K | 173.00K | 285.00K | 44.00K | 41.00K | 29.00K | 40.00K | 105.00K | 21.00K | 240.00K | 257.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 235.53M | 233.24M | 234.60M | 224.35M | 208.72M | 201.42M | 220.24M | 175.56M | 183.21M | 126.87M | 92.05M | 106.10M | 86.90M | 90.60M | 39.08M | 37.75M | 44.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 319.68M | 485.97M | 496.64M | 648.89M | 374.49M | 351.48M | 349.85M | 322.77M | 210.70M | 123.26M | 128.65M | 112.98M | 100.34M | 84.62M | 44.69M | 39.89M | 36.06M | 32.26M | 27.40M | 23.40M | 20.99M | 21.27M | 22.07M | 23.27M | 24.21M | 21.54M | 16.91M | 13.69M | 13.00M | 6.70M | 3.00M | 800.00K |
| EBITDA | 810.84M | 722.69M | 906.89M | 782.18M | 856.74M | 811.49M | 846.12M | 845.12M | 697.18M | 468.57M | 394.33M | 327.95M | 238.13M | 144.67M | 121.66M | 110.47M | 147.74M | 121.17M | 101.35M | 110.38M | 79.80M | 265.63M | 491.37M | -13.86M | 116.26M | 103.37M | 86.18M | 69.12M | 87.40M | 51.20M | 26.60M | 7.40M |
| EBITDA Ratio | 85.38% | 82.29% | 85.33% | 87.65% | 92.25% | 92.07% | 94.32% | 93.83% | 93.79% | 94.34% | 94.34% | 93.92% | 99.78% | 91.74% | 82.21% | 80.76% | 91.93% | 82.09% | 91.95% | 117.95% | 92.50% | 19.70% | 15.78% | -5.03% | 95.00% | 95.07% | 94.90% | 94.52% | 142.35% | 135.45% | 127.88% | 125.42% |
| Operating Income | 761.27M | 390.28M | 564.88M | 452.26M | 551.75M | 497.59M | 261.26M | 509.75M | 411.27M | 345.31M | 265.68M | 214.97M | 137.80M | 148.94M | 115.89M | 104.74M | 111.03M | 89.04M | 66.46M | 60.10M | 46.06M | 10.19M | 17.22M | -17.15M | 92.04M | 81.83M | 69.27M | 55.43M | 74.40M | 44.50M | 23.60M | 6.60M |
| Operating Income Ratio | 80.16% | 44.44% | 53.15% | 50.68% | 59.40% | 56.44% | 28.76% | 56.59% | 55.31% | 68.41% | 63.45% | 61.34% | 47.16% | 57.66% | 58.69% | 54.05% | 69.58% | 65.62% | 62.81% | 66.44% | 53.40% | 7.43% | 6.69% | -6.22% | 75.21% | 75.26% | 76.28% | 75.79% | 121.17% | 117.72% | 113.46% | 111.86% |
| Total Other Income/Expenses | -505.64M | -318.76M | -525.18M | -585.36M | -207.90M | -201.08M | -209.25M | -175.62M | -176.74M | -123.96M | -93.16M | -94.27M | -85.19M | -90.50M | -33.77M | -27.12M | -43.44M | -30.66M | -26.72M | -43.36M | -6.04M | 3.49M | -677.00K | 9.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 255.63M | 436.14M | 416.08M | 162.33M | 343.84M | 296.51M | 105.92M | 384.33M | 234.53M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 77.62M | 67.59M | 58.39M | 36.69M | 16.74M | 40.02M | 13.68M | 16.55M | -7.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 26.92% | 49.66% | 39.15% | 18.19% | 37.02% | 33.63% | 11.66% | 42.66% | 31.54% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.06% | 42.36% | 43.03% | 34.67% | 18.51% | 46.39% | 9.98% | 6.42% | -2.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 6.26M | 4.56M | 3.84M | 4.93M | 2.84M | 3.01M | 3.25M | 1.41M | 1.21M | 126.87M | 92.05M | 106.10M | 112.74M | -4.00K | 753.00K | -72.00K | -7.00K | 2.35M | 28.18M | 43.10M | 29.74M | 23.89M | 34.56M | 22.42M | 72.37M | 5.62M | 24.42M | 20.84M | 51.40M | 26.70M | 12.00M | 2.20M |
| Net Income | 242.18M | 426.93M | 416.74M | 159.33M | 341.12M | 281.58M | 100.42M | 366.42M | 224.52M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 78.14M | 69.37M | 55.70M | 36.69M | 16.74M | 23.03M | -14.65M | -16.66M | -49.56M | 19.67M | 76.21M | 44.85M | 34.59M | 23.00M | 17.80M | 11.60M | 4.40M |
| Net Income Ratio | 25.50% | 48.61% | 39.21% | 17.85% | 36.73% | 31.94% | 11.05% | 40.68% | 30.19% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.33% | 43.48% | 41.05% | 34.67% | 18.51% | 26.70% | -10.68% | -6.47% | -17.97% | 16.07% | 70.08% | 49.38% | 47.30% | 37.46% | 47.09% | 55.77% | 74.58% |
| EPS | 1.04 | 1.81 | 1.76 | 0.70 | 1.60 | 1.41 | 0.51 | 1.91 | 1.30 | 1.75 | 1.47 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| EPS Diluted | 1.00 | 1.75 | 1.71 | 0.68 | 1.54 | 1.34 | 0.51 | 1.90 | 1.29 | 1.74 | 1.46 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| Weighted Avg Shares Out | 240.49M | 236.26M | 236.93M | 227.74M | 213.40M | 200.28M | 197.74M | 191.78M | 172.24M | 126.55M | 117.26M | 107.59M | 102.12M | 94.06M | 83.56M | 75.13M | 65.86M | 58.65M | 51.74M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
| Weighted Avg Shares Out (Dil) | 250.45M | 244.29M | 244.34M | 235.10M | 222.13M | 209.71M | 206.79M | 201.64M | 180.51M | 127.29M | 118.10M | 108.01M | 102.18M | 94.24M | 83.65M | 75.21M | 65.89M | 58.75M | 52.06M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
At-The-Market Issuance By U.S. REITs Hits All-Time Quarterly High In Q3 2024
Total proceeds raised by US equity real estate investment trusts through at-the-market offering programs rocketed to an all-time high in the third quarter. US REITs raised an aggregate of $7.21 billion in proceeds through their at-the-market programs during the quarter....
Omega Healthcare: Back To Pre-Pandemic Levels, But I Think It Consolidates (Rating Downgrade)
OHI produced a strong Q3 beating on the top and bottom line as they came in ahead of the consensus estimate of $0.38 EPS with $0.42. OHI continued to make progress in Q3 having completed $440 million in new investments...
3 Magnificent Dividend Stocks With Yields Above 6% to Buy in December
The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of 2022. However, after the index's two-year bull run, it's getting harder to find quality dividend stocks...
Omega Healthcare Investors: Patience Is Seemingly Paying Off
Omega Healthcare Investors has shown significant improvements, with FFO and revenue beating estimates, and strong growth in tenant payments and new investments in 2024. The REIT's payout ratio has decreased but remains high at 96%; management expects it to fall...
2 Ultra-High-Yield Dividend Stocks That Passive Income Investors Won't Want to Miss
Hundreds of companies pay dividends. Many currently offer higher yields, making them attractive for those seeking passive income.
CIO or OHI: Which Is the Better Value Stock Right Now?
Investors interested in REIT and Equity Trust - Other stocks are likely familiar with City Office REIT (CIO) and Omega Healthcare Investors (OHI). But which of these two stocks is more attractive to value investors?
2 Overpriced REITs To Avoid And 1 Better Buy
Not all REITs are worth buying. Some very popular REITs are today overpriced. I present two of them to avoid and one better alternative.
PEB or OHI: Which Is the Better Value Stock Right Now?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Pebblebrook Hotel (PEB) and Omega Healthcare Investors (OHI). But which of these two companies is the best option for those looking for undervalued stocks?
Beat Back Market Turbulence With These Yields Up To 9%
Election. Recession. No landing. Social unrest. Election contest. Low beta, anyone? Today we'll talk calm in a sea of manic. A six-pack of tranquil dividend payers yielding up to 8.9%.
Omega Healthcare Investors, Inc. (OHI) Q3 2024 Earnings Call Transcript
Omega Healthcare Investors, Inc. (NYSE:OHI ) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET Company Participants Michele Reber - IR Taylor Pickett - CEO Dan Booth - COO Bob Stephenson - CFO Megan Krull - SVP, Operations...
Source: https://incomestatements.info
Category: Stock Reports